凱升控股(00102.HK)正與Suntrust就逾期利息付款安排進行磋商
格隆匯1月16日丨凱升控股(00102.HK)公吿,2020年可換股債券的票面利息自2020年12月30日(即2020年可換股債券發行日期)起計每年支付一次。Suntrust未能於2020年可換股債券條款所規定十五天寬限期屆滿後支付到期日為2022年12月30日的第二年票面利息。
於到期日,票面利息為3.36億菲律賓比索。若就逾期利息的一大部分計提撥備,將對公司截至2022年12月31日止財政年度的溢利造成重大不利影響。公司正與Suntrust就逾期利息的付款安排進行磋商,但於公吿日期尚未達成任何具體計劃。若有任何重大進展,公司將適時吿知其股東及其他投資者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.